AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Cerus Corp
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S97DG4
2.33▲ 0.02 (0.87%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
2.31
Day's Range
2.29 – 2.36
52-Week Range
1.38 – 3.47
Volume
1.9M
Avg Volume
1.9M
Share Statistics
Shares Outstanding
Employees
345
Exchange
XNAS
Listed
1997-01-31
Share count as of July 16, 2026

Cerus Corp (CERS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Cerus Corp (CERS)
What is Cerus Corp's Market Cap?
Cerus Corp's Market Cap is $469.6M, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's Enterprise Value?
Cerus Corp's Enterprise Value is $516.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's Price / Sales?
Cerus Corp's Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's EV / Revenue?
Cerus Corp's EV / Revenue is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's EV / EBITDA?
Cerus Corp's EV / EBITDA is 7828.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's Revenue (TTM)?
Cerus Corp's Revenue (TTM) is $249.2M, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's Net Income (TTM)?
Cerus Corp's Net Income (TTM) is -$6.8M, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's EBITDA?
Cerus Corp's EBITDA is $66.0K, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's Diluted EPS (TTM)?
Cerus Corp's Diluted EPS (TTM) is -0.03, based on as-reported figures from SEC (XBRL) filings.
What is Cerus Corp's EBITDA Margin?
Cerus Corp's EBITDA Margin is 0.0%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CERSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue——
YoY growth+9.5%+24.1%——
Cost of revenue
Gross profit
% of revenue51.4%52.0%——
Government contract revenue——
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue64.9%64.3%——
Loss from operations
% of revenue-3.2%-0.7%——
Non-operating expense, net:
Foreign exchange (loss) gain
Interest expense
Other income, net
Total non-operating expense, net
Loss before income taxes
Provision for income tax
Net loss
% of revenue-5.2%-3.1%——
Net loss attributable to noncontrolling interest
Net loss attributable to Cerus Corporation
% of revenue-5.1%-3.1%——
Net loss per share attributable to Cerus Corporation
Basic
Diluted